台股 » 個股 » 和康生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

和康生

(1783)
可現股當沖
  • 股價
    50.3
  • 漲跌
    ▼1.5
  • 漲幅
    -2.90%
  • 成交量
    219
  • 產業
    上市 生技醫療類股
  • 128人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
和康生 (1783)籌碼相關-臺銀-高雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

臺銀-高雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/20250.10250.9051.2002320.00%
2025/01/16151.2000.0051.0012260.44%
2025/01/1500.00551.2049.30-5222-2.25%
2025/01/13152.9000.0052.0012080.48%
2025/01/101652.70353.3751.70131986.53%
2025/01/0900.00752.3052.30-7190-3.67%
2025/01/08252.9000.0051.7021841.08%
2025/01/0700.001.153.1952.10-1.1176-0.60%
2025/01/062051.5000.0050.802015912.56%
2025/01/0300.001350.3850.10-13146-8.85%
2025/01/02349.2500.0049.0031372.19%
2024/12/3100.00048.8548.9501370.00%
2024/12/301949.4300.0048.851913713.81%
2024/12/273448.14048.5048.653413125.77%
2024/12/1900.00246.1346.30-2128-1.56%
2024/12/1200.00149.0048.40-1126-0.79%
2024/12/1100.00348.6248.65-3121-2.47%
2024/12/10147.00346.8746.70-2106-1.88%
2024/12/0600.00146.2046.20-1105-0.95%
2024/12/0500.00145.8046.00-1102-0.97%
2024/11/2000.00042.2542.4001060.00%
2024/11/18141.90041.8041.9011110.89%
2024/11/0800.00143.5543.80-1120-0.83%
2024/11/0700.00142.1042.15-1115-0.86%
2024/11/0400.00041.7042.1001260.00%
2024/10/28143.0000.0042.8011380.72%
2024/10/2300.00042.0042.1001490.00%
2024/10/2200.00142.1042.40-1152-0.66%
2024/10/2100.00042.2042.2001580.00%
2024/10/0700.00143.6043.50-1245-0.41%
2024/09/271.542.7200.0042.351.52980.50%
2024/09/25142.600.143.2943.200.93780.24%
2024/09/230.142.7500.0042.150.13850.02%
2024/09/2000.00042.9042.7503920.00%
2024/09/1200.00245.2545.25-2398-0.50%
2024/09/1100.00145.7045.15-1406-0.25%
2024/09/1000.00145.5045.15-1408-0.24%
2024/09/0900.00145.3045.15-1407-0.25%
2024/09/0500.00045.0045.2504090.00%
2024/09/0400.00245.0345.00-2413-0.48%
2024/09/0300.00146.5046.10-1413-0.24%
2024/09/0200.00046.5546.5504140.00%
2024/08/3000.00146.7046.55-1419-0.24%
2024/08/2900.00046.3046.5504320.00%
2024/08/2800.00246.6846.55-2432-0.46%
2024/08/2700.00246.2046.50-2432-0.46%
2024/08/26146.0000.0046.1014300.23%
2024/08/2300.003.445.8146.10-3.4429-0.79%
2024/08/2100.00045.0045.1004300.00%
2024/08/2000.00144.0044.05-1427-0.23%
2024/08/1400.00143.1543.20-1425-0.24%
2024/08/1300.00042.9543.1004250.00%
2024/08/0900.002.141.6942.00-2.1421-0.49%
2024/08/05338.703.138.4138.10-0.1412-0.01%
2024/08/02042.49042.9242.3004060.00%
2024/08/01043.6000.0043.6504030.00%
2024/07/31043.3900.0043.1004020.00%
2024/07/30042.9600.0043.7004020.00%
2024/07/29042.5000.0043.0004010.01%
2024/07/26044.4800.0044.3003960.00%
2024/07/2300.000.145.8045.55-0.1393-0.01%
2024/07/22045.8200.0046.5003910.01%
2024/07/19048.78647.8046.50-6384-1.56%
2024/07/18047.90547.7948.00-5346-1.44%
2024/07/17045.2000.0044.9003280.00%
2024/07/160.245.0000.0044.750.23280.06%
2024/07/15045.3000.0045.2003310.00%
2024/07/11045.300.145.2045.000329-0.01%
2024/07/10145.3000.0045.3513290.31%
2024/07/092.345.9000.0044.052.33290.71%
2024/07/08247.5000.0047.0023110.64%
2024/07/05049.80249.4049.40-2300-0.66%
2024/07/03150.7000.0050.4012840.35%
2024/07/02350.67250.1050.4012620.38%
2024/07/0100.001150.0250.20-11214-5.12%
2024/06/1200.001544.9744.80-15157-9.55%
2024/06/051544.7800.0044.90151539.79%
2024/05/27242.1300.0041.9521401.42%
2024/05/17143.4000.0043.6011350.74%
2024/05/16143.2000.0043.1511340.74%
2024/04/29142.6500.0042.6011550.64%
2024/04/26142.5000.0042.2511550.64%
2024/04/19142.35242.2842.05-1163-0.61%
2024/04/17243.9000.0044.0021591.25%
2024/04/08145.3500.0045.3011650.60%
2024/03/19345.0000.0044.9031661.80%
2024/03/18145.5000.0045.6011660.60%
2024/03/13244.850.145.5044.7021661.17%
2024/03/1200.001.145.2045.60-1.1166-0.63%
2024/03/11045.5000.0044.7001650.00%
2024/02/2700.00247.6047.60-2178-1.12%
2024/02/21047.95047.9547.7001880.00%
2024/02/19048.4000.0048.0501900.00%
2024/02/16148.1000.0047.9511900.52%
2024/02/1500.00046.9047.000191-0.01%
2024/02/0500.00546.7546.60-5187-2.66%
2024/02/02547.40047.7047.3051872.64%
2024/02/01045.7500.0045.7501820.00%
〈大江集團法說〉和康生明年營收續拚雙位數成長 淨利率維持25%Anue鉅亨-2023/11/20
和康生三大業務銷售看旺 明、後年將啟動擴產計畫Anue鉅亨-2023/07/25
和康生全年毛利率有望維持67%水準 今年將取得10張認證Anue鉅亨-2023/05/23
和康生 相關文章